article thumbnail

No Plaque, No Problem: Tackling Atherosclerosis Prevention

Cardiometabolic Health Congress

While advances in treatment have reduced mortality in some regions, the atherosclerosis prevention remains challenging. This shift results from an epidemiologic transition: as infectious diseases decline, chronic conditions like atherosclerosis dominate.

article thumbnail

Winning the Battle Against Atherosclerosis: Practical, Proactive Solutions

Cardiometabolic Health Congress

Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. The Way Forward: Turning Research into Real-World Change The fight against atherosclerosis requires proactive, evidence-based action. But what if prevention could rewrite the narrative?

article thumbnail

Association between periodontal disease and atherosclerosis: a bibliometric analysis

Frontiers in Cardiovascular Medicine

BackgroundIn recent years, the relationship between periodontal disease (PD) and atherosclerosis (AS) has garnered significant scholarly attention. Keyword analysis reveals “atherosclerosis,” “periodontal disease,” “cardiovascular disease,” “Porphyromonas gingivalis,” and “periodontal pathogens” as research hotspots.

article thumbnail

Cholesterol crystals in the pathogenesis of atherosclerosis

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 18 November 2024; doi:10.1038/s41569-024-01100-3 Cholesterol crystals (CCs) have a pathogenic role in various cardiovascular diseases, particularly atherosclerosis.

article thumbnail

Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis

Frontiers in Cardiovascular Medicine

Atherosclerosis, the leading cause of death worldwide, is a chronic inflammatory disease leading to the accumulation of lipid-rich plaques in the intima of large and medium-sized arteries. Accumulating evidence indicates the important regulatory role of the adaptive immune system in atherosclerosis during all stages of the disease.

article thumbnail

Subclinical Atherosclerosis Burden Shapes All-Cause Mortality Risk

HCPLive

Subclinical atherosclerosis burden and its progression are independently linked to the risk of death from any cause in asymptomatic individuals.

article thumbnail

Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis

Cardiovascular Diabetology

Elevated glycated hemoglobin (HbA1c) is associated with a higher burden of subclinical atherosclerosis (SA). However, the association with SA of earlier insulin resistance markers is poorly understood. The stu.